Experimental Evaluation of the Combined Effects of a GLP-1 Agonist and a SGLT2 Inhibitor in a Metabolic Syndrome Model. RJTDS [Internet]. 2025 Dec. 4 [cited 2026 Oct. 26];4(12):1-8. Available from: https://journals.academiczones.net/index.php/rjtds/article/view/6138